Derek Lowe, like many, is waiting to see how the Pfizer layoffs will pan out. Planning for months now to cut research staff, Pfizer still hasn't lowered the ax, but Lowe predicts that the changes will be "quite profound in chemistry. Pfizer seems to be dividing its chemists up into people who think up molecules, and people who make them, with no real overlap," he writes at In the Pipeline. He also predicts that outsourcing will be taken to a whole new level. The worst part, though, is having to sit and wait for the news for months on end, he says, adding, "the way this is being done has not reflected well on the company's management and how it treats its employees."
Just Do It Already, Pfizer
Dec 12, 2008